Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.53% | 15.61% | 15.18% | 15.91% | 16.55% |
| Total Other Revenue | 12.71% | 46.46% | 32.49% | -21.52% | -25.12% |
| Total Revenue | 15.51% | 15.78% | 15.30% | 15.55% | 16.09% |
| Cost of Revenue | 12.55% | 15.89% | 17.97% | 22.45% | 22.38% |
| Gross Profit | 16.98% | 15.72% | 14.02% | 12.38% | 13.22% |
| SG&A Expenses | 28.61% | 13.23% | 12.40% | 3.20% | -17.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.64% | 16.89% | 16.79% | 12.40% | -2.60% |
| Operating Income | -62.58% | 0.17% | -4.59% | 109.52% | 237.48% |
| Income Before Tax | -35.66% | -32.34% | -29.80% | 4.57% | 194.22% |
| Income Tax Expenses | 55.71% | 80.28% | 49.81% | 30.15% | 107.73% |
| Earnings from Continuing Operations | -57.69% | -49.21% | -41.10% | -3.97% | 169.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.17% | 59.38% | 53.64% | 10.15% | -157.55% |
| Net Income | -53.15% | -43.61% | -33.33% | -0.59% | 178.72% |
| EBIT | -62.58% | 0.17% | -4.59% | 109.52% | 237.48% |
| EBITDA | -44.83% | 14.03% | 14.41% | 86.45% | 394.57% |
| EPS Basic | -57.34% | -47.47% | -38.18% | 2.76% | 169.82% |
| Normalized Basic EPS | -50.59% | 72.18% | 89.47% | 166.20% | 412.24% |
| EPS Diluted | -62.96% | -53.62% | -44.62% | -11.46% | 166.54% |
| Normalized Diluted EPS | -50.10% | 62.32% | 78.78% | 194.57% | 290.22% |
| Average Basic Shares Outstanding | 4.24% | 2.62% | 1.90% | 2.08% | 3.53% |
| Average Diluted Shares Outstanding | -7.90% | -0.62% | -1.66% | 8.76% | 33.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |